Functional phenotyping and genotyping of circulating tumor cells from patients with castration resistant prostate cancer

被引：64
|
作者：
Paris, Pamela L. [1 ]
Kobayashi, Yasuko [1 ]
Zhao, Qiang [2 ]
Zeng, Wei [3 ]
Sridharan, Shivaranjani [1 ]
Fan, Tina [2 ]
Adler, Howard L. [2 ]
Yera, Emmanuel R. [1 ]
Zarrabi, M. H. [4 ]
Zucker, Stanley [4 ]
Simko, Jeffry [1 ]
Chen, Wen-Tien [2 ,3 ]
Rosenberg, Jonathan [5 ]
机构：
[1] Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA
[2] SUNY Stony Brook, Ctr Canc, Stony Brook, NY 11794 USA
[3] Vitatex Inc, Stony Brook, NY 11790 USA
[4] Vet Adm Med Ctr, Northport, NY 11768 USA
[5] Univ Calif San Francisco, Div Hematol & Oncol, San Francisco, CA 94115 USA
来源：
CANCER LETTERS | 2009年 / 277卷 / 02期
关键词：
Prostate cancer; Metastasis; Circulating tumor cells; Blood micrometastases; DNA COPY NUMBER; COMPARATIVE GENOMIC HYBRIDIZATION; HIGH-RESOLUTION ANALYSIS; BREAST-CANCER; PERIPHERAL-BLOOD; OLIGONUCLEOTIDE CGH; ADHESION MOLECULE; BONE-MARROW; METASTASIS; ARRAY;
D O I：
10.1016/j.canlet.2008.12.007
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Circulating tumor cells (CTCs) hold promise for studying advanced prostate cancer. A functional collagen adhesion matrix (CAM) assay was used to enrich CTCs from prostate cancer patients' blood. CAM ingestion and epithelial immuno-staining identified CTCs, which were genotyped using oligonucleotide array comparative genomic hybridization. The highest CTC counts were observed in men with metastatic castration resistant prostate cancer (CRPC) compared to castration sensitive prostate cancer. Copy number profiles for CRPC CTCs were similar to paired solid tumor DNA, and distinct from corresponding DNA from the residual CAM-depleted blood. CAM CTC enrichment may allow cellular and genetic analyses in prostate cancer. (c) 2008 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码：164 / 173
页数：10
相关论文
共 50 条
  • [1] Circulating tumor cells in patients with castration resistant prostate cancer
    Danila, Daniel C.
    ACTA ENDOCRINOLOGICA-BUCHAREST, 2008, 4 (01) : 75 - 75
  • [2] Detection and Characterization of Invasive Circulating Tumor Cells Derived from Men with Metastatic Castration- Resistant Prostate Cancer
    Friedlander, Terence W.
    Ngo, Vy T.
    Dong, Huan
    Premasekharan, Gayatri
    Weinberg, Vivian
    Doty, Shaun
    Zhao, Qiang
    Gilbert, Elizabeth G.
    Ryan, Charles J.
    Chen, Wen-Tien
    Paris, Pamela L.
    INTERNATIONAL JOURNAL OF CANCER, 2014, 134 (10) : 2284 - 2293
  • [3] Association of Circulating Tumor Cells with Inflammatory and Biomarkers in the Blood of Patients with Metastatic Castration-Resistant Prostate Cancer
    Theil, Gerit
    Lindner, Carlotta
    Bialek, Joanna
    Fornara, Paolo
    LIFE-BASEL, 2021, 11 (07):
  • [4] Circulating Tumor Cells in Metastatic Castration-Resistant Prostate Cancer
    Rini, Brian I.
    CURRENT ONCOLOGY REPORTS, 2009, 11 (03) : 163 - 164
  • [5] Circulating tumor cells in metastatic castration-resistant prostate cancer
    Brian I. Rini
    Current Oncology Reports, 2009, 11 : 163 - 164
  • [6] Dissemination of Circulating Tumor Cells in Breast and Prostate Cancer: Implications for Early Detection
    Bae, Song Yi
    Kamalanathan, Kaylee Judith
    Galeano-Garces, Catalina
    Konety, Badrinath R.
    Antonarakis, Emmanuel S.
    Parthasarathy, Jayant
    Hong, Jiarong
    Drake, Justin M.
    ENDOCRINOLOGY, 2024, 165 (04)
  • [7] The End of the Beginning: Circulating Tumor Cells As a Biomarker in Castration-Resistant Prostate Cancer
    Friedlander, Terence W.
    Fong, Lawrence
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (11) : 1104 - +
  • [8] Circulating tumor cells and advanced prostate cancer
    Murez, Thibaut
    Droupy, Stephane
    Rebillard, Xavier
    Alix-Panabieres, Catherine
    BULLETIN DU CANCER, 2012, 99 : S4 - S15
  • [9] Phenotypic and genetic heterogeneity of tumor tissue and circulating tumor cells in patients with metastatic castration-resistant prostate cancer: a report from the PETRUS prospective study
    Massard, Christophe
    Oulhen, Marianne
    Le Moulec, Sylvestre
    Auger, Nathalie
    Foulon, Stephanie
    Abou-Lovergne, Aurelie
    Billiot, Fanny
    Valent, Alexander
    Marty, Virginie
    Loriot, Yohann
    Fizazi, Karim
    Vielh, Philippe
    Farace, Francoise
    ONCOTARGET, 2016, 7 (34) : 55069 - 55082
  • [10] The use of circulating tumor cells in guiding treatment decisions for patients with metastatic castration-resistant prostate cancer
    Onstenk, Wendy
    de Kiaver, Willemijn
    de Wit, Ronald
    Lolkema, Martijn
    Foekens, John
    Sleijfer, Stefan
    CANCER TREATMENT REVIEWS, 2016, 46 : 42 - 50
12345